Association of NOD2/CARD15 SNP mutations with early and late complications of allogeneic haematopoietic stem cell transplantation - a single-centre experience

被引：0
|
作者：
Holowiecka-Goral, A.
Giebel, S.
Wojnar, J.
Grudziecka, E.
Oczko, M.
Jarzab, B.
机构：
[1] Silesian Univ Med, Katowice, Poland
[2] Inst Oncol, Gliwice, Poland
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [31] NOD2/CARD15 VARIANTS ARE NOT A RISK FACTOR FOR CLINICAL OUTCOME AFTER NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    van der Straaten, H.
    Paquay, M.
    Tilanus, M.
    van Geloven, N.
    Verdonck, L.
    Huisman, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 647 - 647
  • [32] No direct effect of NOD2/CARD15 variants on clinical outcome after non-myeloablative allogeneic stem cell transplantation
    van der Straaten, H. M.
    Paquay, M. M.
    Tilanus, M. G. J.
    van Geloven, N.
    Verdonck, L. F.
    Huisman, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S287 - S288
  • [33] Myeloablative treosulfan as preparative regimen for allogeneic haematopoietic stem cell transplantation: a single-centre experience
    Trenschel, R
    Ditschkowski, M
    Elmaagacli, A
    Steckel, N
    Hlinka, M
    Peceny, R
    Ottinger, H
    Koldehoff, M
    Biersack, H
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2004, 33 : S33 - S34
  • [34] Myeloablative treosulfan as preparative regimen for allogeneic haematopoietic stem cell transplantation: a single-centre experience
    Trenschel, R
    Ditschkowski, M
    Elmaagacli, A
    Steckel, N
    Hlinka, M
    Peceny, R
    Ottinger, H
    Koldehoff, M
    Biersack, H
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S217 - S218
  • [35] Allogeneic haematopoietic stem cell transplantation in Jehova's Witnesses is feasible - a single-centre experience
    Wendelin, K.
    Dressler, S.
    Schaefer-Eckart, K.
    Wilhelm, M.
    Wandt, H.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S404 - S404
  • [36] Allogeneic haematopoietic stem cell transplantation in myelofibrosis: single-centre experience at the University Hospital in Bratislava
    Bojtarova, E.
    Ziakova, B.
    Zwiewka, M.
    Sopko, L.
    Demeckova, E.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S151 - S151
  • [37] Treatment of relapse after allogeneic haematopoietic stem cell transplantation. A single-centre experience
    Markova, M
    Vitek, A
    Pohlreich, D
    Valkova, V
    Cetkovsky, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S341 - S341
  • [38] Allogeneic haematopoietic stem cell transplantation for relapsed/refractory acute leukaemia - a single-centre experience
    Tan, T. D.
    Wu, M. C.
    Chiou, J. L. W.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S94 - S95
  • [39] Allogeneic haematopoietic stem cell transplantation for primary immunodeficiency diseases in Korea: a single-centre experience
    Yoo, K. H.
    Son, M. H.
    Lee, S. H.
    Sung, K.
    Kim, Y. J.
    Ahn, K. M.
    Chueh, H. W.
    Koo, H. H.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S382 - S382
  • [40] Stem cell transplantation of patients with a NOD2/CARD15 polymorphism for SNP12 and SNP13 reveal a reduced over all survival
    Richter, Rudolf
    Widmann, Elena
    Schulz, Miriam
    Serve, Hubert
    Bug, Gesine
    Seifried, Erhard
    Martin, Hans
    Seidl, Christian
    TISSUE ANTIGENS, 2010, 75 (05): : 557 - 557
12345